Covered recipient · General Payments record
OSHER RECHESTER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2024
$709.85
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $709.85 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $172.65 | 1 |
| EISAI INC. | $165.05 | 3 |
| ABBVIE INC. | $163.97 | 7 |
| Novo Nordisk AS | $125.01 | 1 |
| Lundbeck LLC | $48.29 | 2 |
| SCILEX PHARMACEUTICALS INC. | $19.23 | 1 |
| Neuronetics, Inc. | $15.65 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $709.85 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.00 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926905 | CMS |
| ABBVIE INC. | $34.62 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926907 | CMS |
| ABBVIE INC. | $24.16 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926909 | CMS |
| ABBVIE INC. | $14.52 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926911 | CMS |
| ABBVIE INC. | $6.50 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926913 | CMS |
| ABBVIE INC. | $31.53 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926915 | CMS |
| ABBVIE INC. | $28.64 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926917 | CMS |
| Eisai Inc. | $125.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110771211 | CMS |
| Eisai Inc. | $20.73 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110771215 | CMS |
| Eisai Inc. | $19.32 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110771213 | CMS |
| Lundbeck LLC | $26.00 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145960064 | CMS |
| Lundbeck LLC | $22.29 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145960066 | CMS |
| Neurocrine Biosciences, Inc. | $172.65 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150806116 | CMS |
| Neuronetics, Inc. | $15.65 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073310036 | CMS |
| Novo Nordisk Inc | $125.01 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097255359 | CMS |
| SCILEX PHARMACEUTICALS INC. | $19.23 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282946 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.